B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy

References

• Brenner H, Hoffmeister M. [Colorectal cancer screening: evidence and implementation]. Darmkrebsfruherkennung: evidenz und Umsetzung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(3):302–306. German. doi:10.1007/s00103-013-1911-2
   PubMed Web of Science ®Google Scholar
• Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375(9719):1030–1047. doi:10.1016/S0140-6736(10)60353-4
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. doi:10.1038/s41575-019-0189-8
   PubMed Web of Science ®Google Scholar
• Veldkamp R, Gholghesaei M, Bonjer HJ, et al. Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES). Surg Endosc. 2004;18(8):1163–1185. doi:10.1007/s00464-003-8253-3
   PubMed Web of Science ®Google Scholar
• Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305(22):2335–2342. doi:10.1001/jama.2011.749
   PubMed Web of Science ®Google Scholar
• Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22(1):23–30. doi:10.1200/JCO.2004.09.046
   PubMed Web of Science ®Google Scholar
• Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci. 2020;111(9):3142–3154. doi:10.1111/cas.14532
   PubMed Web of Science ®Google Scholar
• Lee S, LaCour TG, Fuchs PL. Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines † This review is dedicated to the community of isolation/identification natural product detectives, with special thanks to the groups of Bob Pettit and Nobuhiro Fusatani. Chem Rev. 2009;109(6):2275–2314. doi:10.1021/cr800365m
   PubMedGoogle Scholar
• Juhás M, Zitko J. Molecular Interactions of Pyrazine-Based Compounds to Proteins. J Med Chem. 2020;63(17):8901–8916. doi:10.1021/acs.jmedchem.9b02021
   PubMed Web of Science ®Google Scholar
• Dolezal M, Zitko J. Pyrazine derivatives: a patent review (June 2012 – present). Expert Opin Ther Pat. 2015;25(1):33–47. doi:10.1517/13543776.2014.982533
   PubMed Web of Science ®Google Scholar
• Miniyar BP, Murumkar RP, Patil SP, Barmade AM, Bothara GK. Unequivocal role of pyrazine ring in medicinally important compounds: a review. Mini Rev Med Chem. 2013;13(11):1607–1625. doi:10.2174/1389557511313110007
   PubMed Web of Science ®Google Scholar
• Dubuisson MLN, Rees JF, Marchand-Brynaert J. Discovery and validation of a new family of antioxidants: the aminopyrazine derivatives. Mini Rev Med Chem. 2004;4(4):421–435. doi:10.2174/1389557043403927
   PubMed Web of Science ®Google Scholar
• Huigens RW, Brummel BR, Tenneti S, Garrison AT, Xiao T. Pyrazine and phenazine heterocycles: platforms for total synthesis and drug discovery. Molecules. 2022;27(3):1112. doi:10.3390/molecules27031112
   PubMed Web of Science ®Google Scholar
• Dhiman N, Kaur K, Jaitak V. Tetrazoles as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. Bioorg Med Chem. 2020;28(15):115599. doi:10.1016/j.bmc.2020.115599
   PubMed Web of Science ®Google Scholar
• Gao F, Xiao J, Huang G. Current scenario of tetrazole hybrids for antibacterial activity. Eur J Med Chem. 2019;184:111744. doi:10.1016/j.ejmech.2019.111744
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang S, Ba Y, Xu Z. Tetrazole hybrids with potential anticancer activity. Eur J Med Chem. 2019;178:341–351. doi:10.1016/j.ejmech.2019.05.071
   PubMed Web of Science ®Google Scholar
• Gao C, Chang L, Xu Z, et al. Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem. 2019;163:404–412. doi:10.1016/j.ejmech.2018.12.001
   PubMed Web of Science ®Google Scholar
• Myznikov LV, Vorona SV, Zevatskii YE. Biologically active compounds and drugs in the tetrazole series. Chem Heteroc Comp. 2021;57(3):224–233. doi:10.1007/s10593-021-02897-4
   Web of Science ®Google Scholar
• Neochoritis CG, Zhao T, Dömling A. Tetrazoles via multicomponent reactions. Chem Rev. 2019;119(3):1970–2042. doi:10.1021/acs.chemrev.8b00564
   PubMed Web of Science ®Google Scholar
• Herr RJ. 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. Bioorg Med Chem. 2002;10(11):3379–3393. doi:10.1016/S0968-0896(02)00239-0
   PubMed Web of Science ®Google Scholar
• Wächter GA, Davis MC, Martin AR, Franzblau SG. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. J Med Chem. 1998;41(13):2436–2438. doi:10.1021/jm9708745
   PubMed Web of Science ®Google Scholar
• Tisseh ZN, Dabiri M, Nobahar M, Soorki AA, Bazgir A. Catalyst-free synthesis of N-rich heterocycles via multi-component reactions. Tetrahedron. 2012;68(16):3351–3356. doi:10.1016/j.tet.2012.02.051
   Web of Science ®Google Scholar
• Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K. Engineering the third wave of biocatalysis. Nature. 2012;485(7397):185–194. doi:10.1038/nature11117
   PubMed Web of Science ®Google Scholar
• Hanefeld U, Hollmann F, Paul CE. Biocatalysis making waves in organic chemistry. Chem Soc Rev. 2022;51(2):594–627. doi:10.1039/D1CS00100K
   PubMed Web of Science ®Google Scholar
• Li F, Tang X, Xu Y, et al. A dual-protein cascade reaction for the regioselective synthesis of quinoxalines. Org Lett. 2020;22(10):3900–3904. doi:10.1021/acs.orglett.0c01186
   PubMed Web of Science ®Google Scholar
• Li F, Su J, Xu Y, et al. A glucose oxidase-hemoglobin system for efficient oxysulfonylation of alkenes/alkynes in water. Molecul Cata. 2021;500:111336. doi:10.1016/j.mcat.2020.111336
   Web of Science ®Google Scholar
• Yang Y, Arnold FH. Navigating the unnatural reaction space: directed evolution of heme proteins for selective carbene and nitrene transfer. Acc Chem Res. 2021;54(5):1209–1225. doi:10.1021/acs.accounts.0c00591
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323–335. doi:10.1038/nature09782
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410. doi:10.1038/nrc3262
   PubMed Web of Science ®Google Scholar
• Zhao RY, Fu JH, Zhu LJ, Chen Y, Liu B. Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy. J Hematol Oncol. 2022;15(1). doi:10.1186/s13045-022-01230-6
   Web of Science ®Google Scholar
• Ismail NI, Othman I, Abas F, Naidu R, Naidu R. The curcumin analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), inhibits cell proliferation and induces apoptosis in primary and metastatic human colon cancer cells. Molecules. 2020;25(17):3798. doi:10.3390/molecules25173798
   PubMed Web of Science ®Google Scholar
• Brockmueller A, Buhrmann C, Shayan P, Shakibaei M. Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment. Front Immunol. 2023;14:1225530. doi:10.3389/fimmu.2023.1225530
   PubMed Web of Science ®Google Scholar
• Flanagan L, Meyer M, Fay J, et al. Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: caspase-3 inhibition as a therapeutic approach. Cell Death Dis. 2016;7(2):e2087. doi:10.1038/cddis.2016.7
   PubMedGoogle Scholar
• Sun C, Liu H, Guo J, et al. MicroRNA-98 negatively regulates myocardial infarction-induced apoptosis by down-regulating Fas and caspase-3. Sci Rep. 2017;7(1):7460. doi:10.1038/s41598-017-07578-x
   PubMedGoogle Scholar
• Zhang Y, Fang J, Ma H. Inhibition of miR-182-5p protects cardiomyocytes from hypoxia-induced apoptosis by targeting CIAPIN1. Biochem Cell Biol. 2018;96(5):646–654. doi:10.1139/bcb-2017-0224
   PubMedGoogle Scholar
• Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Bio. 2022;221(6):e202201159. doi:10.1083/jcb.202201159
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 2002;9(4):358–361. doi:10.1038/sj.cdd.4400989
   PubMed Web of Science ®Google Scholar
• Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem. 2009;284(33):21777–21781. doi:10.1074/jbc.R800084200
   PubMed Web of Science ®Google Scholar
• Julien O, Wells JA. Caspases and their substrates. Cell Death Differ. 2017;24(8):1380–1389. doi:10.1038/cdd.2017.44
   PubMed Web of Science ®Google Scholar
• Jin P, Jiang J, Xie N, et al. MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling. Cell Death Dis. 2019;10(8):615. doi:10.1038/s41419-019-1844-2
   PubMedGoogle Scholar
• Wei Y, An Z, Zou Z, et al. The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. Elife. 2015;4. doi:10.7554/eLife.05289
   Web of Science ®Google Scholar
• Izadi M, Ali TA, Pourkarimi E. Over fifty years of life, death, and cannibalism: a historical recollection of apoptosis and autophagy. Int J Mol Sci. 2021;22(22):12466. doi:10.3390/ijms222212466
   PubMed Web of Science ®Google Scholar
• Song S, Tan J, Miao Y, Li M, Zhang Q. Crosstalk of autophagy and apoptosis: involvement of the dual role of autophagy under ER stress. J Cell Physiol. 2017;232(11):2977–2984. doi:10.1002/jcp.25785
   PubMed Web of Science ®Google Scholar
• Su W, Liao M, Tan H, et al. Identification of autophagic target RAB13 with small-molecule inhibitor in low-grade glioma via integrated multi-omics approaches coupled with virtual screening of traditional Chinese medicine databases. Cell Prolif. 2021;54(12):e13135. doi:10.1111/cpr.13135
   PubMed Web of Science ®Google Scholar
• Tian SS, Chen Y, Yang B, et al. F1012-2 inhibits the growth of triple negative breast cancer through induction of cell cycle arrest, apoptosis, and autophagy. Phytother Res. 2018;32(5):908–922. doi:10.1002/ptr.6030
   PubMed Web of Science ®Google Scholar
• Gornowicz A, Szymanowska A, Mojzych M, Czarnomysy R, Bielawski K, Bielawska A. The anticancer action of a novel 1,2,4-triazine sulfonamide derivative in colon cancer cells. Molecules. 2021;26(7):2045. doi:10.3390/molecules26072045
   PubMed Web of Science ®Google Scholar
• Huang Q, Zhan L, Cao H, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016;12(6):999–1014. doi:10.1080/15548627.2016.1166318
   PubMed Web of Science ®Google Scholar
• Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998;72(11):8586–8596. doi:10.1128/JVI.72.11.8586-8596.1998
   PubMed Web of Science ®Google Scholar
• Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther. 2013;14(2):100–107. doi:10.4161/cbt.22954
   PubMed Web of Science ®Google Scholar
• Kang KF, Wang XW, Chen XW, Tan GM, Kang ZJ. [Expression of Beclin1 in primary hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(1):151–153. Chinese.
   PubMedGoogle Scholar
• Feng ML, Sun MJ, Xu BY, Liu MY, Zhang HJ, Wu C. Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer. World J Gastroenterol. 2023;29(24):3770–3792. doi:10.3748/wjg.v29.i24.3770
   PubMed Web of Science ®Google Scholar
• Freeman K, Saunders MP, Uthman OA, et al. Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review. BMC Cancer. 2016;16:523. doi:10.1186/s12885-016-2581-x
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Abak A, Tondro Anamag F, et al. 5-Fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent. Front Oncol. 2021;11:658636. doi:10.3389/fonc.2021.658636
   PubMed Web of Science ®Google Scholar
• Entezar-Almahdi E, Mohammadi-Samani S, Tayebi L, Farjadian F. Recent advances in designing 5-fluorouracil delivery systems: a stepping stone in the safe treatment of colorectal cancer. Int J Nanomedicine. 2020;15:5445–5458. doi:10.2147/ijn.S257700
   PubMed Web of Science ®Google Scholar
• Chauvin A, Bergeron D, Vencic J, et al. Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells. BMC Cancer. 2022;22(1):363. doi:10.1186/s12885-022-09417-3
   PubMed Web of Science ®Google Scholar
• McQuade RM, Stojanovska V, Bornstein JC, Nurgali K. Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem. 2017;24(15):1537–1557. doi:10.2174/0929867324666170111152436
   PubMed Web of Science ®Google Scholar